Your browser doesn't support javascript.
loading
CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels, Mia; Riva, Matteo; Bennet, Hedvig; Ahlqvist, Emma; Dyachok, Oleg; Nagaraj, Vini; Shcherbina, Liliya; Fred, Rikard G; Poon, Wenny; Sörhede-Winzell, Maria; Fadista, Joao; Lindqvist, Andreas; Kask, Lena; Sathanoori, Ramasri; Dekker-Nitert, Marloes; Kuhar, Michael J; Ahrén, Bo; Wollheim, Claes B; Hansson, Ola; Tengholm, Anders; Fex, Malin; Renström, Erik; Groop, Leif; Lyssenko, Valeriya; Wierup, Nils.
Afiliação
  • Abels M; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Riva M; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Bennet H; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Ahlqvist E; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Dyachok O; Department of Medical Cell Biology, Uppsala University Biomedical Centre, Uppsala, Sweden.
  • Nagaraj V; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Shcherbina L; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Fred RG; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Poon W; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Sörhede-Winzell M; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Fadista J; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Lindqvist A; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Kask L; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Sathanoori R; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Dekker-Nitert M; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Kuhar MJ; The Yerkes Research Center of Emory University, Atlanta, GA, USA.
  • Ahrén B; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Wollheim CB; Department of Cell Physiology and Metabolism, University Medical Centre, Geneva, Switzerland.
  • Hansson O; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Tengholm A; Department of Medical Cell Biology, Uppsala University Biomedical Centre, Uppsala, Sweden.
  • Fex M; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Renström E; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Groop L; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Lyssenko V; Lund University Diabetes Centre, Skåne University Hospital, Lund and Malmö, Sweden.
  • Wierup N; Steno Diabetes Center A/S, Gentofte, Denmark.
Diabetologia ; 59(9): 1928-37, 2016 09.
Article em En | MEDLINE | ID: mdl-27338624
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucagon / Diabetes Mellitus Tipo 2 / Insulina / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucagon / Diabetes Mellitus Tipo 2 / Insulina / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia